Royalty Pharma plc Class A Ordinary Shares (RPRX) — Analysis Summary
Royalty Pharma plc Class A Ordinary Shares (RPRX) has a market cap of $23.80B with year-over-year revenue growth of +5.1%. Net margin stands at 32.4%. The stock trades at a P/E ratio of 28.8.
Key Takeaways
- Revenue changed +5.1% year-over-year
- Net margin of 32.4%
- P/E ratio of 28.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, RPRX posted revenue growth of +5.1% and trades at a P/E of 28.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.